Skip to content

Regenxbio RGNX Taxes Paid

Taxes Paid at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$1.73M+107%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$14.64M+41.0%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$7.72K-30.7%
Xencor logo
XencorXNCR
$3.01M
Sutro Biopharma logo
Sutro BiopharmaSTRO
-$15K-314%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$265.75K+221%

Other financials

Income statement

See full
Revenue$6.4M-92.8%
Gross profit$14.9M+35.7%
Operating income-$83.4M-787%
Net income-$90.1M-1,580%
EPS (diluted)-$1.72-1,533%

Balance sheet

See full
Cash & equivalents$15.2M-88.3%
Total debt$71.1M-11.0%
Total equity$21.1M-92.3%
Total assets$341.9M-30.4%

Cash flow

See full
Operating cash flow-$76.2M-327%
CapEx$1.2M+20.6%
Free cash flow-$77.4M-337%

Valuation

See full
Market cap$529.38M+24.6%
Enterprise value$585.22M+56.3%
P/S+3.3×

Profitability

See full
Gross margin59.7%+1.0pp
Operating margin-292.3%-613pp
Net margin-330.2%-588pp
FCF margin-269.2%-364pp

Returns & leverage

See full
Return on equity-196.4%-288pp
Debt / equity3.4×+3.1×
Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Regenxbio’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's taxes paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Regenxbio's taxes paid?
Regenxbio (RGNX) reported taxes paid of $71.25K in Q4 2025.
How has Regenxbio's taxes paid changed year-over-year?
Regenxbio's taxes paid increased by 495.8% year-over-year, from -$18K to $71.25K.
What is the long-term trend for Regenxbio's taxes paid?
Over 4 years (2021 to 2025), Regenxbio's taxes paid has grown at a -53.3% compound annual growth rate (CAGR), from $6M to $285K.
What does taxes paid mean?
Actual cash paid to tax authorities for income taxes during the period — may differ from income tax expense due to timing.